TickerFacts.

Cosmos Health Inc. (COSM): R&D Expense

Annual figures by period end, from SEC filings.

$519.4K
Year ended 2025-12-31
$497.6K
Trailing 12 months to 2026-06-30
$533.3K2023-12-31: $164.9K2024-12-31: $533.3K2025-12-31: $519.4K$519.4K
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$519.4K-2.6%2026-04-15, From 2025-01-01
2024-12-31$533.3K+223.5%2026-04-15, From 2024-01-01
2023-12-31$164.9Kn/a2025-04-15, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Cosmos Health Inc. (COSM)2025-12-31$519.4K-2.6%
Stemtech Corp (STEK)2025-12-31$0n/a
Nu Skin Enterprises, Inc. (NUS)2025-12-31$10.80M-16.9%

Compare COSM, STEK, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗